State of New Jersey Common Pension Fund D’s Alnylam Pharmaceuticals ALNY Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.9M	Sell	42,883 -2,268	-5%	-$684K	0.04%	313
2026 Q1	$14.9M	Buy	45,151 +175	+0.4%	+$59.6K	0.06%	270
2025 Q4	$17.9M	Sell	44,976 -556	-1%	-$246K	0.06%	234
2025 Q3	$20.8M	Buy	45,532 +1,673	+4%	+$681K	0.08%	211
2025 Q2	$14.3M	Buy	43,859 +114	+0.3%	+$31.5K	0.06%	278
2025 Q1	$11.8M	Sell	43,745 -3,758	-8%	-$966K	0.05%	310
2024 Q4	$11.2M	Buy	47,503 +70	+0.1%	+$18.4K	0.05%	347
2024 Q3	$13M	Sell	47,433 -1,025	-2%	-$267K	0.05%	306
2024 Q2	$11.8M	Sell	48,458 -24,801	-34%	-$3.92M	0.05%	311
2024 Q1	$10.9M	Hold	73,259	–	–	0.03%	435
2023 Q4	$14M	Buy	73,259 +1,674	+2%	+$285K	0.05%	353
2023 Q3	$12.7M	Sell	71,585 -2,208	-3%	-$421K	0.05%	363
2023 Q2	$14M	Hold	73,793	–	–	0.05%	366
2023 Q1	$14.8M	Buy	73,793 +1,561	+2%	+$328K	0.05%	348
2022 Q4	$17.2M	Hold	72,232	–	–	0.06%	300
2022 Q3	$14.5M	Sell	72,232 -727	-1%	-$139K	0.06%	313
2022 Q2	$10.6M	Buy	72,959 +1,060	+1%	+$150K	0.04%	396
2022 Q1	$11.7M	Hold	71,899	–	–	0.04%	423
2021 Q4	$12.2M	Hold	71,899	–	–	0.04%	442
2021 Q3	$13.6M	Hold	71,899	–	–	0.04%	396
2021 Q2	$12.2M	Buy	71,899 +611	+0.9%	+$89.5K	0.04%	425
2021 Q1	$10.1M	Sell	71,288 -3,285	-4%	-$494K	0.04%	469
2020 Q4	$9.69M	Sell	74,573 -3,621	-5%	-$483K	0.03%	465
2020 Q3	$11.4M	Sell	78,194 -1,153	-1%	-$164K	0.05%	366
2020 Q2	$11.8M	Sell	79,347 -3,755	-5%	-$506K	0.05%	360
2020 Q1	$9.05M	Hold	83,102	–	–	0.04%	389
2019 Q4	$9.57M	Buy	83,102 +6,602	+9%	+$658K	0.04%	479
2019 Q3	$6.15M	Sell	76,500 -3,500	-4%	-$277K	0.02%	657
2019 Q2	$5.8M	Hold	80,000	–	–	0.02%	555
2019 Q1	$7.48M	Hold	80,000	–	–	0.03%	491
2018 Q4	$5.83M	Hold	80,000	–	–	0.02%	508
2018 Q3	$7M	Hold	80,000	–	–	0.03%	515
2018 Q2	$7.88M	Buy	+80,000	New	+$7.93M	0.03%	480

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of New Jersey Common Pension Fund D's ALNY Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Alnylam Pharmaceuticals (ALNY) stake by 5% in Q2 2026, selling an estimated $684K and leaving 42,883 shares worth $12.9M. The position accounts for 0.04% of the portfolio, ranked #313.

State of New Jersey Common Pension Fund D first reported a position in ALNY in Q2 2018 and has held it in 33 quarters since. The position peaked at $20.8M in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

State of New Jersey Common Pension Fund D held 42,883 shares of Alnylam Pharmaceuticals worth $12.9M as of Q2 2026.
State of New Jersey Common Pension Fund D sold 2,268 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $684K.
Alnylam Pharmaceuticals made up 0.04% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #313 holding.
State of New Jersey Common Pension Fund D first reported a position in Alnylam Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
State of New Jersey Common Pension Fund D's Alnylam Pharmaceuticals position peaked at $20.8M in Q3 2025.
793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.